Sabra Health Care REIT Hits New 52-Week High at $21.07

Sabra Health Care REIT, Inc. has reached a significant milestone by hitting a new 52-week high of USD 21.07 on February 27, 2026. This achievement underscores the company's strong performance in the realty sector, particularly within the small-cap market, where it boasts a market capitalization of USD 5,025 million. Over the past year, Sabra Health Care REIT has demonstrated impressive growth, with a performance increase of 46.06%, significantly outpacing the S&P 500's 17.36% gain during the same period. The company's price-to-earnings (P/E) ratio stands at 24.00, reflecting its valuation in the current market environment. Additionally, Sabra Health Care REIT offers a remarkable dividend yield of 552.13%, which is noteworthy for income-focused investors. With a price-to-book ratio of 1.78 and a return on equity of 5.87%, Sabra Health Care REIT continues to position itself as a notable player in the realty industry. The stock's previous 52-week low was recorded at USD 15.75, highlighting the significant upward movement in its price.